For the Inventor, By the Inventor

Enter assignee name

Cambridge, United Kingdom

Paion UK Limited

USPTO Granted Patents = 21

CIPO Patents = 17

EPO Patents = 8

Forward Citations = 116

Loading Chart...

Loading Chart...

36 inventors (with patents filed for the assignee):

Gary Stuart Tilbrook (18 out of 18 patents)

Keith Borkett (8 out of 8 patents)

Hugh Wiltshire (8 out of 8 patents)

4. Karin Wilhelm-Ogunbiyi (8 out of 8 patents)

5. Louisa Jane Quegan (5 out of 6 patents)

6. Yuji Kawakami (3 out of 3 patents)

7. Tatsushi Murase (3 out of 3 patents)

8. Daisuke Tanaka (3 out of 3 patents)

9. Hideyuki Yoshiyama (3 out of 3 patents)

10. Shinitsu Kuwabe (3 out of 3 patents)

11. Andreas Schumacher (3 out of 7 patents)

12. Rene Emmenegger (2 out of 2 patents)

13. Louisa Jane Cubitt (2 out of 2 patents)

14. René Emmenegger (1 out of 1 patent)

15. Karl-Uwe Petersen (1 patent)

21 patents: Sort by Forward Citations

1. 12365684 - Short-acting benzodiazepine salts and their polymorphic forms (2025-07-22),

2. 12201637 - Dosing regimen for sedation with CNS 7056 (Remimazolam) (2025-01-21),

3. 10961250 - Short-acting benzodiazepine salts and their polymorphic forms (2021-03-30),

4. 10722522 - Dosing regimen for sedation with CNS 7056 (remimazolam) (2020-07-28),

5. 10472365 - Short-acting benzodiazepine salts and their polymorphic forms (2019-11-12),

6. 10414749 - Process for preparing 3-[(S)-7-bromo-2-((2-oxopropyl)amino)-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]propionic acid methyl ester (2019-09-17),

7. 10342800 - Dosing regimen for sedation with CNS 7056 (Remimazolam) (2019-07-09),

8. 10195210 - Dosing regimen for sedation with CNS 7056 (Remimazolam) (2019-02-05),

9. 10052334 - Dosing regimen for sedation with CNS 7056 (remimazolam) (2018-08-21),

10. 10000464 - Process for preparing 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4H-imidazo[1,2-A][1,4]benzodiazepine-4-yl]propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process (2018-06-19),

11. 9981941 - Process for preparing 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl]propionic acid methyl ester benzenesulfonate (2018-05-29),

12. 9914738 - Short-acting benzodiazepine salts and their polymorphic forms (2018-03-13),

13. 9827251 - Dosing regimen for sedation with CNS 7056 (remimazolam) (2017-11-28),

14. 9777007 - Short-acting benzodiazepine salts and their polymorphic forms (2017-10-03),

15. 9737547 - Dosing regimen for sedation with CNS 7056 (Remimazolam) (2017-08-22),

PAION UK LIMITED is a pharmaceutical company focused on the development and commercialization of innovative drugs for anesthesia and critical care. Their mission is to improve patient outcomes and enhance healthcare with their portfolio of high-quality medicines. Through strategic partnerships and collaborations, PAION UK LIMITED aims to address unmet medical needs and make a positive impact in the field of anesthesia and critical care.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

21 Patents

#46 in Cambridge

#836 in United Kingdom

#29,031 in the World

Cambridge, United Kingdom

Paion UK Limited

Forward Citations = 116

36 inventors:

Gary Stuart Tilbrook (18 out of 18 patents)

Keith Borkett (8 out of 8 patents)

Hugh Wiltshire (8 out of 8 patents)

4. Karin Wilhelm-Ogunbiyi (8 out of 8 patents)

5. Louisa Jane Quegan (5 out of 6 patents)

Please report any incorrect information to support@idiyas.com

Loading…